(Q33837258)

29 July 2017

1 reference

title

Quality of life instruments in oncology (English)

1 reference

29 July 2017

1 reference

1

Velikova G

1 reference

29 July 2017

Stark D

2

1 reference

PubMed ID

10673964

29 July 2017

Selby P

series ordinal

3

1 reference

29 July 2017

1 October 1999

1 reference

European Journal of Cancer

29 July 2017

1 reference

29 July 2017

35

1 reference

29 July 2017

11

1 reference

29 July 2017

1571-1580

1 reference

Existential well-being is an important determinant of quality of life. Evidence from the McGill Quality of Life Questionnaire.

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

The Sexual Activity Questionnaire: a measure of women's sexual functioning.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

The European Organization for Research and Treatment of Cancer. Approach to quality of life assessment: guidelines for developing questionnaire modules. EORTC Study Group on Quality of Life.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: an update and overview. EORTC Quality of Life Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

The Sickness Impact Profile: Development and Final Revision of a Health Status Measure

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

CAncer Rehabilitation Evaluation System--short form (CARES-SF). A cancer specific rehabilitation and quality of life instrument

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

The development of a method for assessing the quality of life of cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

On the receiving end—II. Linear analogue self-assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Measuring the quality of life of cancer patients: a concise QL-index for use by physicians.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Quality of life in stage II breast cancer: an instrument for clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

A SELF-RATING DEPRESSION SCALE

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Self-rating symptom checklists: a simple method for recording and evaluating symptom control in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Screening for anxiety and depression in cancer patients: the effects of disease and treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Measurement of health status. Ascertaining the minimal clinically important difference

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Interpretation of quality of life changes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Assessing the minimal important difference in symptoms: a comparison of two techniques.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Effect sizes for interpreting changes in health status.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Monitoring dialysis patients' health status.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Quality of life of Danish women: population-based norms of the EORTC QLQ-C30.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Interpreting the significance of changes in health-related quality-of-life scores.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Research on health-related quality of life: dissemination into practical applications.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Lessons learned from measuring health-related quality of life in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Quality of life during cytostatic therapy for advanced symptomatic colorectal carcinoma: a randomized comparison of two regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Guidelines for reporting results of quality of life assessments in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Quality of life assessment in clinical trials--guidelines and a checklist for protocol writers: the U.K. Medical Research Council experience. MRC Cancer Trials Office.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Science, language, intuition, and the many meanings of quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Teaching senior oncologists communication skills: results from phase I of a comprehensive longitudinal program in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Communication skills and psychological training in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Quality of life and the patient with cancer. Individual and policy implications

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Oncologists' recognition of depression in their patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Improving physicians' recognition and treatment of depression in general medical care. Results from a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Quality of life in breast cancer patients: the contribution of data to the care of patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Who should measure quality of life, the doctor or the patient?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

The use of the Hospital Anxiety and Depression Scale (HADS) and the EORTC QLQ-C30 questionnaires to screen for treatable unmet needs in patients attending routinely for radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Barriers to the use of health status measures in clinical investigation, patient care, and policy research

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Strategies for improving and expanding the application of health status measures in clinical settings. A researcher-developer viewpoint

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Automated collection of quality-of-life data: a comparison of paper and computer touch-screen questionnaires

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Patients' experiences using a computerized program with a touch-sensitive video monitor for the assessment of health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Health status reports in the care of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Improving patient function: a randomized trial of functional disability screening.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Functional disability screening of ambulatory patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Improving patient quality of life with feedback to physicians about functional status.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Patient-based health status measurement in clinical practice: a study of its impact on epilepsy patients' care

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Quality of life assessment in daily clinical oncology practice: a feasibility study.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

The impact of recombinant human erythropoietin on medical care costs for hemodialysis patients in Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Generic health measurement: past accomplishments and a measurement paradigm for the 21st century

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Health status assessment for the twenty-first century: item response theory, item banking and computer adaptive testing

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Establishing equivalence between scaled measures of quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Deriving a preference-based single index from the UK SF-36 Health Survey.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Measurement of health state utilities for economic appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Methodology for measuring health-state preferences--IV: Progress and a research agenda

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Methodology for measuring health-state preferences--II: Scaling methods

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

EuroQol--a new facility for the measurement of health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Healthy years equivalents versus time trade-off. Ambiguity on certainty and uncertainty.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Relationship between health utility and psychometric health status measures

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Quality of life measures in health care. III: Resource allocation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

The use of QALYs in health care decision making

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

EuroQol: the current state of play

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Measuring patients' views: the optimum outcome measure

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

The cost-effectiveness of routine postoperative radiotherapy after sector resection and axillary dissection for breast cancer stage I. Results from a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

A quality-of-life-oriented endpoint for comparing therapies.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Evaluation of effectiveness: Q-TWiST. The International Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Quality-of-life-adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: an Eastern Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Trials and tribulations. Emerging issues in designing economic evaluations alongside clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Economics notes: types of economic evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Health economics and quality of life in cancer trials: report based on a UKCCCR workshop. United Kingdom Coordinating Committee on Cancer Research

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Constructing health state preference values from descriptive quality of life outcomes: mission impossible?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

Methodological and statistical issues of quality of life (QoL) and economic evaluation in cancer clinical trials: report of a workshop.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

The hospital anxiety and depression scale

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900193-8

7 January 2021

10.1016/S0959-8049(99)00193-8

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wawhroql6bg4dkh45mksparxcy

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_wawhroql6bg4dkh45mksparxcy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wawhroql6bg4dkh45mksparxcy

30 July 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/wawhroql6bg4dkh45mksparxcy

30 July 2022